4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis.

4-Hydroxynonenal (HNE) is by far the most investigated aldehydic end-product of oxidative breakdown of membrane n-6 polyunsaturated fatty acids. Its potential involvement in the pathogenesis of atherosclerosis has been corroborated by its consistent detection in both oxidized LDL and fibrotic plaque in humans. HNE has been shown to activate both macrophage and smooth muscle cells, i.e. the two key cell types in chronic inflammatory processes characterized by excessive fibrogenesis. By signalling to the nucleus, the aldehyde may up-regulate in these cells both expression and synthesis of monocyte chemotactic protein 1 (MCP-1) and transforming growth factor beta1 (TGFbeta1). Oxysterols, namely 27 carbon atoms oxidation products of cholesterol, are found in relatively high amount in LDL from hypercholesterolemic individuals and are consistently detectable in foam cells and necrotic core of human atherosclerotic lesion. As for HNE, the challenge of cells of the macrophage lineage with a mixture of oxysterols like that detectable in hypercholesterolemic individuals led to a marked overexpression of TGFbeta1 and MCP-1. Both HNE and oxysterols then appear to be candidates for a primary role in the progression of the atherosclerotic process.

[1]  G. Poli,et al.  Oxidative stress and cell signalling. , 2004, Current medicinal chemistry.

[2]  G. Keszler,et al.  Capillary electrophoresis study on DNA-protein complex formation in the polymorphic 5' upstream region of the dopamine D4 receptor (DRD4) gene. , 2004, Current medicinal chemistry.

[3]  G. Poli,et al.  Trojan horse-like behavior of a biologically representative mixture of oxysterols. , 2004, Molecular aspects of medicine.

[4]  I. Björkhem,et al.  On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. , 2002, Journal of lipid research.

[5]  G. Poli,et al.  Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). , 2002, The Journal of nutritional biochemistry.

[6]  Daniel Steinberg,et al.  Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.

[7]  F. Guardiola.  Cholesterol and Phytosterol Oxidation Products: Analysis, Occurrence, and Biological Effects , 2002 .

[8]  M. Nitti,et al.  Activation of PKC-β isoforms mediates HNE-induced MCP-1 release by macrophages , 2002 .

[9]  I. Björkhem,et al.  Oxysterols: Friends, Foes, or Just Fellow Passengers? , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[10]  A. Sevanian,et al.  Up‐regulation of the fibrogenic cytokine TGF‐β1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Smondyrev,et al.  Effects of oxygenated sterol on phospholipid bilayer properties: a molecular dynamics simulation. , 2001, Chemistry and physics of lipids.

[12]  C. Bode,et al.  4-Hydroxynonenal induces apoptosis, NF-κB-activation and formation of 8-isoprostane in vascular smooth nmuscle cells , 2001, Basic Research in Cardiology.

[13]  G. Poli,et al.  4‐Hydroxynonenal in the Pathomechanisms of Oxidative Stress , 2000, IUBMB life.

[14]  A. Sevanian,et al.  Lipid oxidation products in cell signaling. , 2000, Free radical biology & medicine.

[15]  M. Tabaton,et al.  Oxidative Stress Induces Increase in Intracellular Amyloid β-Protein Production and Selective Activation of βI and βII PKCs in NT2 Cells , 2000 .

[16]  C. Kretz-remy,et al.  Gene expression and thiol redox state. , 1999, Methods in enzymology.

[17]  R. Coleman,et al.  Macrophage Enrichment with the Isoflavan Glabridin Inhibits NADPH Oxidase-induced Cell-mediated Oxidation of Low Density Lipoprotein , 1999, The Journal of Biological Chemistry.

[18]  M. Nitti,et al.  Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4‐hydroxy‐2,3‐nonenal: A signaling pathway to modulate vesicular transport of glycoproteins , 1999, Hepatology.

[19]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[20]  G. Bellomo,et al.  HNE interacts directly with JNK isoforms in human hepatic stellate cells. , 1998, The Journal of clinical investigation.

[21]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[22]  P. Golay,et al.  Determination of Cholesterol Oxidation Products in Milk Powders: Methods Comparison and Validation , 1998 .

[23]  C. Bode,et al.  Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. , 1998, Circulation.

[24]  J L Witztum,et al.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. , 1997, The Journal of clinical investigation.

[25]  C. Tournier,et al.  Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase). , 1997, European journal of biochemistry.

[26]  U. Diczfalusy,et al.  The oxysterols cholest-5-ene-3β,4α-diol, cholest-5-ene-3β,4β-diol and cholestane-3β,5α,6α-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques , 1996 .

[27]  C. van der Veen,et al.  Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. , 1995, Biochimica et biophysica acta.

[28]  I. Dianzani,et al.  Vitamin E dietary supplementation inhibits transforming growth factor β1 gene expression in the rat liver , 1992, FEBS letters.

[29]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[30]  J. Steinberg.  Book ReviewAmbulatory Pediatric Care , 1989 .

[31]  C. B. Taylor,et al.  Cholesterol oxidation derivatives and arterial endothelial damage. , 1985, Atherosclerosis.

[32]  G. Schroepfer,et al.  Oxysterols: modulators of cholesterol metabolism and other processes. , 2000, Physiological reviews.

[33]  S. Milani,et al.  Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[34]  G. Poli,et al.  Biogenic 4‐hydroxy‐2‐nonenal activates transcription factor AP‐1 but not NF‐κB in cells of the macrophage lineage , 1997, BioFactors.

[35]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[36]  T. Carew,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.